Industry Verticals »

All Categories

Insights »

About TMR »

Breast Imaging Market

Breast Imaging Market (Technology: Ionizing Breast Imaging [Mammography, Positron Emission Tomography-Computed Tomography {PET-CT}, and Molecular Breast Imaging {MBI}], Nonionizing Breast Imaging [Breast Ultrasound, Breast MRI, Breast Thermography, and Automated Whole-breast Ultrasound {AWBU}], and Others; and End User: Hospitals & Clinics, Diagnostic Centers, Ambulatory Surgical Centers, and Research Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2028

AI and ML Create Lucrative Opportunities for Early Detection of Lesions

AI (Artificial Intelligence) and ML (Machine Learning) are virtually penetrating almost all industries, including healthcare. These technologies are generating incremental opportunities for companies in the breast imaging market. The alarming rate of women in the U.S. that may be susceptible to breast cancer during their lifetime has led to the adoption of AI and ML to improve patient quality of life. The market in the U.S., one of the major economies of North America, is anticipated to generate the highest revenue and is predicted for exponential growth. There is a growing need for early detection and increased awareness among patients in the market for breast imaging.

Early detection of lesions with the help of AI and ML has helped to improve clinical numbers. This phenomena is being further leveraged with advanced screening mammography, whereas this technique is gaining global recognition as one of the most effective methods for detecting early breast cancer. This explains why ionizing breast imaging dictates the highest revenue among all technologies in the breast imaging market.

breast imaging technologies market infographic

Digital Breast Imaging and Patient Communication Improve Clinical Outcomes

Early cancer detection has become one of the important prerequisites for most women worldwide. Hence, healthcare companies are gaining expertise in digital breast imaging to improve cancer diagnosis. Such advancements are boosting the revenue of breast imaging market, which is estimated to be valued at ~US$ 7 Bn by the end of 2028. On the other hand, clinicians are building their credibility by gaining efficacy in FDA-approved technologies for breast imaging. Such technologies are supporting a wide range of clinical research studies and the development of innovative products related to breast cancer.

Apart from innovations in the breast imaging market, clinicians are creating an awareness about radiologist-patient communication as the key to offer a more patient-centric atmosphere in hospitals and clinics. Thus, along with innovations in breast imaging, healthcare providers need to understand that patients are more willing to interact with their radiologist, while being educated about their individual circumstances.

DBT Outperforms DM in Detection of Poor Prognosis Cancers

Advantages offered by tomosynthesis are anticipated to outperform the offerings of digital mammography. However, in the current scenario, the rapidly evolving COVID-19 (Coronavirus) has forced stakeholders to cancel and reschedule important conferences associated with breast imaging. For instance, the 2020 Society of Breast Imaging/American College of Radiology (SBI/ACR) annual symposium has been cancelled and rescheduled for April 8 - April 11, 2021, in Savannah, Georgia, U.S. Such unwelcome pandemics are slowing down the pace of innovations in the breast imaging market. Hence, healthcare companies are taking cues from previous and ongoing research materials available at their disposal.

Newly published studies are offering important insights to technology companies that are shifting their focus to digital breast tomosynthesis (DBT) from digital mammography (DM). Thus, the breast imaging market is continuously growing due to largely consolidated players dominating ~45%-50% of the market share in 2018. The DBT is being highly publicized for effective breast imaging in order to reduce the incidences of false positives.

breast imaging technologies market segmentation
Analysts’ Viewpoint

The analysts of Transparency Market Research (TMR) anticipate that improved radiologist-patient communication is building the credibility of hospitals and clinics, thus making breast imaging widely accepted in developing economies of Asia Pacific. The breast imaging market is undergoing transformation with the introduction of AI and ML in early detection of lesions.

Moreover, DBT is gaining popularity over DM as a powerful tool for breast cancer screening. However, the volume of published data on DBT is limited to only first round of screening, thus creating ambiguity about the performance of the DBT over prolonged periods of time. Hence, companies should increase their efficacy in five-year research studies and more to create the availability of enough clinical data about DBT in order to establish its widespread application.

Breast Imaging Market: Overview

  • Breast imaging techniques involve capturing of images of breast tissues that assist in diagnosis and screening of breast cancer. Various technologies that are used to image breast tissues include mammography, breast MRI, breast ultrasound, and molecular imaging.
  • Mammography is considered as a standard technique to screen breast tissues. Breast MRI and breast ultrasound are used in combination with mammography for detailed and clear imaging of breast tissues.
  • The breast imaging market has experienced tremendous growth in the past decade, due to factors such as increased awareness about benefits of early breast cancer detection and high prevalence of breast cancer
  • Different types of technologies are used in breast imaging, including ionizing breast imaging and nonionizing breast imaging

Breast Imaging Market: Drivers

  • High Incidence of breast cancer and aging demographics are projected to boost the growth of the breast imaging market. According to the World Health Organization (WHO) statistics published in December 2018, 2.1 million new cases were diagnosed with breast cancer in 2018, which is 11.6% of the total cancer incidence burden. Breast cancer was the cause of death of 627,000 women globally in 2018. Out of 184 countries in the world, breast cancer is frequently diagnosed in 140 countries.
  • According to the World Cancer Research Fund, the number of breast cancer cases is likely to reach to 2.1 million by 2030
  • One of the major factors influencing the growth of this industry is increasing government initiative to increase awareness about breast cancer. Under the NBCCEDP, CDC offers mammograms and pap tests free of cost or at low price to those women who have low income and little or no insurance coverage. In order to encourage breast screening in the country, the U.S. Government passed the Breast and Cervical Cancer Mortality Prevention Act of 1990.

Market Segmentation: Breast Imaging Market

  • Based on technology, the global breast imaging market has been divided into ionizing breast imaging (mammography, positron emission tomography-computed tomography (PET-CT), and molecular breast imaging (MBI)); nonionizing breast imaging (breast ultrasound, breast MRI, breast thermography, and automated whole-breast ultrasound (AWBU)); and others
  • In terms of end user, the global market has been categorized into hospitals & clinics, diagnostic centers, ambulatory surgical centers, and research centers
  • Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The report provides current and future revenue (US$ Mn) for each of these segments from 2018 to 2028, considering 2019 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2020 to 2028 along with market size estimations.

Regional Overview: Breast Imaging Market

  • In terms of region, the global breast imaging market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
  • The current and future market value in terms of revenue (US$ Mn) of these regional markets and their major countries have been provided in the report from 2018 to 2028, with their CAGRs from 2020 to 2028
  • The study also offers a list of recommendations, highlights, and useful insights of the market which would help new companies willing to enter the market and existing companies to increase market shares, and help in the decision-making process

Breast Imaging Market: Major Players

  • The report concludes with the company profiles section that includes key information about major players in the market
  • Leading players analyzed in the report include
    • GE Healthcare
    • Koninklijke Philips N.V.
    • Hologic, Inc.
    • Siemens Healthineers
    • Fujifilm Holding Corporation
    • Canon Medical Systems Corporation
    • Aurora Imaging Technologies, Inc.
    • Dilon Technologies, Inc.,
    • Leica Biosystems Nussloch GmbH (Danaher).
  • Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Frequently Asked Questions

What is the total market worth of breast imaging market?

Breast imaging market is estimated to be valued at US$ 7 Bn by the end of 2028

What is the anticipated CAGR of the breast imaging market in the forecast period?

Breast imaging market is projected to expand at a CAGR of 8% from 2020 to 2028

What are the key driving factors for the growth of the breast imaging market?

Breast imaging market is driven by growing preference for mammography screening

Which region is expected to project the highest market share in the global breast imaging market?

North America accounted for a major share of the global breast imaging market and the trend is anticipated to continue during the forecast period

Who are the key players in the breast imaging market?

Key players in the global breast imaging market include GE Healthcare, Koninklijke Philips N.V., Hologic, Inc., Siemens Healthineers, Fujifilm Holding Corporation

1. Preface

    1.1. Report Scope and Market Segmentation

    1.2. Research Highlights

2. Assumptions and Research Methodology

    2.1. Assumptions

    2.2. Research Methodology

3. Executive Summary

    3.1. Global Breast Imaging Market Snapshot

4. Market Overview

    4.1. Product Overview

    4.2. Key Industry Events

    4.3. Market Dynamics

    4.4. Drivers and Restraints Snapshot Analysis

        4.4.1. Drivers

        4.4.2. Restraints

        4.4.3. Opportunities

    4.5. Global Breast Imaging Market Revenue Projection

    4.6. Global Breast Imaging Market Outlook

5. Market Outlook

    5.1. Breast Cancer Incidence and Mortality Rate, by Region in 2018

    5.2. Global Risk of Breast Cancer

    5.3. Top Three Players Operating in the Market Space

6. Global Breast Imaging Market Analysis, by Technology

    6.1. Introduction

    6.2. Global Breast Imaging Market Value Share and Attractiveness Analysis, by Technology

    6.3. Global Breast Imaging Market Forecast, by Technology

        6.3.1. Ionizing Breast Imaging

            6.3.1.1. Mammography

                6.3.1.1.1. Analog Mammography

                6.3.1.1.2. Digital Mammography

            6.3.1.2. Positron Emission Tomography-Computed Tomography (PET-CT)

            6.3.1.3. Molecular Breast Imaging (MBI)

        6.3.2. Non-ionizing Breast Imaging

            6.3.2.1. Breast Ultrasound

            6.3.2.2. Breast MRI

            6.3.2.3. Breast Thermography

            6.3.2.4. Automated Whole-breast Ultrasound (AWBU)

        6.3.3. Others

    6.4. Global Breast Imaging Market Analysis, by Technology

7. Global Breast Imaging Market Analysis, by End-user

    7.1. Introduction

    7.2. Global Breast Imaging Market Value Share and Attractiveness Analysis, by End-user

    7.3. Global Breast Imaging Market Forecast, by End-user

        7.3.1. Hospitals & Clinics

        7.3.2. Diagnostic Centers

        7.3.3. Ambulatory Surgical Centers

        7.3.4. Research Centers

    7.4. Global Breast Imaging Market Analysis, by End-user

8. Global Breast Imaging Market Analysis, by Region

    8.1. Global Breast Imaging Market Scenario, by Country

    8.2. Global Breast Imaging Market Value Share and Attractiveness Analysis, by Region

    8.3. Global Breast Imaging Market Forecast, by Region

        8.3.1. North America

        8.3.2. Europe

        8.3.3. Asia Pacific

        8.3.4. Latin America

        8.3.5. Middle East & Africa

9. North America Breast Imaging Market Analysis

    9.1. Key Findings

    9.2. North America Breast Imaging Market Overview

    9.3. North America Breast Imaging Market Value Share and Attractiveness Analysis, by Country

    9.4. North America Breast Imaging Market Forecast, by Country

        9.4.1. U.S.

        9.4.2. Canada

    9.5. North America Breast Imaging Market Value Share and Attractiveness Analysis, by Technology

    9.6. North America Breast Imaging Market Forecast, by Technology

        9.6.1. Ionizing Breast Imaging

            9.6.1.1. Mammography

                9.6.1.1.1. Analog Mammography

                9.6.1.1.2. Digital Mammography

            9.6.1.2. Positron Emission Tomography-Computed Tomography (PET-CT)

            9.6.1.3. Molecular Breast Imaging (MBI)

        9.6.2. Non-ionizing Breast Imaging

            9.6.2.1. Breast Ultrasound

            9.6.2.2. Breast MRI

            9.6.2.3. Breast Thermography

            9.6.2.4. Automated Whole-breast Ultrasound (AWBU)

        9.6.3. Others

    9.7. North America Breast Imaging Market Value Share and Attractiveness Analysis, by End-user

    9.8. North America Breast Imaging Market Forecast, by End-user

        9.8.1. Hospitals & Clinics

        9.8.2. Diagnostic Centers

        9.8.3. Ambulatory Surgical Centers

        9.8.4. Research Centers

10. Europe Breast Imaging Market Analysis

    10.1. Key Findings

    10.2. Europe Breast Imaging Market Overview

    10.3. Europe Breast Imaging Market Value Share and Attractiveness Analysis, by Country/Sub-region

    10.4. Europe Breast Imaging Market Forecast, by Country/Sub-region

        10.4.1. Germany

        10.4.2. France

        10.4.3. Italy

        10.4.4. Spain

        10.4.5. U.K.

        10.4.6. Rest of Europe

    10.5. Europe Breast Imaging Market Value Share and Attractiveness Analysis, by Technology

    10.6. Europe Breast Imaging Market Forecast, by Technology

        10.6.1. Ionizing Breast Imaging

            10.6.1.1. Mammography

                10.6.1.1.1. Analog Mammography

                10.6.1.1.2. Digital Mammography

            10.6.1.2. Positron Emission Tomography-Computed Tomography (PET-CT)

            10.6.1.3. Molecular Breast Imaging (MBI)

        10.6.2. Non-ionizing Breast Imaging

            10.6.2.1. Breast Ultrasound

            10.6.2.2. Breast MRI

            10.6.2.3. Breast Thermography

            10.6.2.4. Automated Whole-breast Ultrasound (AWBU)

        10.6.3. Others

    10.7. Europe Breast Imaging Market Value Share and Attractiveness Analysis, by End-user

    10.8. Europe Breast Imaging Market Forecast, by End-user

        10.8.1. Hospitals & Clinics

        10.8.2. Diagnostic Centers

        10.8.3. Ambulatory Surgical Centers

        10.8.4. Research Centers

11. Asia Pacific Breast Imaging Market Analysis

    11.1. Key Findings

    11.2. Asia Pacific Breast Imaging Market Overview

    11.3. Asia Pacific Breast Imaging Market Value Share and Attractiveness Analysis, by Country/Sub-region

    11.4. Asia Pacific Breast Imaging Market Forecast, by Country/Sub-region

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Asia Pacific Breast Imaging Market Value Share and Attractiveness Analysis, by Technology

    11.6. Asia Pacific Breast Imaging Market Forecast, by Technology

        11.6.1. Ionizing Breast Imaging

            11.6.1.1. Mammography

                11.6.1.1.1. Analog Mammography

                11.6.1.1.2. Digital Mammography

            11.6.1.2. Positron Emission Tomography-Computed Tomography (PET-CT)

            11.6.1.3. Molecular Breast Imaging (MBI)

        11.6.2. Non-ionizing Breast Imaging

            11.6.2.1. Breast Ultrasound

            11.6.2.2. Breast MRI

            11.6.2.3. Breast Thermography

            11.6.2.4. Automated Whole-breast Ultrasound (AWBU)

        11.6.3. Others

    11.7. Asia Pacific Breast Imaging Market Value Share and Attractiveness Analysis, by End-user

    11.8. Asia Pacific Breast Imaging Market Forecast, by End-user

        11.8.1. Hospitals & Clinics

        11.8.2. Diagnostic Centers

        11.8.3. Ambulatory Surgical Centers

        11.8.4. Research Centers

12. Latin America Breast Imaging Market Analysis

    12.1. Key Findings

    12.2. Latin America Breast Imaging Market Overview

    12.3. Latin America Breast Imaging Market Value Share and Attractiveness Analysis, by Country/Sub-region

    12.4. Latin America Breast Imaging Market Forecast, by Country/Sub-region

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Latin America Breast Imaging Market Value Share and Attractiveness Analysis, by Technology

    12.6. Latin America Breast Imaging Market Forecast, by Technology

        12.6.1. Ionizing Breast Imaging

            12.6.1.1. Mammography

                12.6.1.1.1. Analog Mammography

                12.6.1.1.2. Digital Mammography

            12.6.1.2. Positron Emission Tomography-Computed Tomography (PET-CT)

            12.6.1.3. Molecular Breast Imaging (MBI)

        12.6.2. Non-ionizing Breast Imaging

            12.6.2.1. Breast Ultrasound

            12.6.2.2. Breast MRI

            12.6.2.3. Breast Thermography

            12.6.2.4. Automated Whole-breast Ultrasound (AWBU)

        12.6.3. Others

    12.7. Latin America Breast Imaging Market Value Share and Attractiveness Analysis, by End-user

    12.8. Latin America Breast Imaging Market Forecast, by End-user

        12.8.1. Hospitals & Clinics

        12.8.2. Diagnostic Centers

        12.8.3. Ambulatory Surgical Centers

        12.8.4. Research Centers

13. Middle East & Africa Breast Imaging Market Analysis

    13.1. Key Findings

    13.2. Middle East & Africa Breast Imaging Market Overview

    13.3. Middle East & Africa Breast Imaging Market Value Share and Attractiveness Analysis, by Country/Sub-region

    13.4. Middle East & Africa Breast Imaging Market Forecast, by Country/Sub-region

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Middle East & Africa Breast Imaging Market Value Share and Attractiveness Analysis, by Technology

    13.6. Middle East & Africa Breast Imaging Market Forecast, by Technology

        13.6.1. Ionizing Breast Imaging

            13.6.1.1. Mammography

                13.6.1.1.1. Analog Mammography

                13.6.1.1.2. Digital Mammography

            13.6.1.2. Positron Emission Tomography-Computed Tomography (PET-CT)

            13.6.1.3. Molecular Breast Imaging (MBI)

        13.6.2. Non-ionizing Breast Imaging

            13.6.2.1. Breast Ultrasound

            13.6.2.2. Breast MRI

            13.6.2.3. Breast Thermography

            13.6.2.4. Automated Whole-breast Ultrasound (AWBU)

        13.6.3. Others

    13.7. Middle East & Africa Breast Imaging Market Value Share and Attractiveness Analysis, by End-user

    13.8. Middle East & Africa Breast Imaging Market Forecast, by End-user

        13.8.1. Hospitals & Clinics

        13.8.2. Diagnostic Centers

        13.8.3. Ambulatory Surgical Centers

        13.8.4. Research Centers

14. Competition Analysis

    14.1. Global Breast Imaging Market Share Analysis, by Company (2018)

    14.2. Competition Matrix

    14.3. Company Profile

        14.3.1. GE Healthcare (General Electric Company)

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Financial Overview

            14.3.1.3. Product Portfolio

            14.3.1.4. SWOT Analysis

            14.3.1.5. Strategic Overview

        14.3.2. Koninklijke Philips N.V.

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Financial Overview

            14.3.2.3. Product Portfolio

            14.3.2.4. SWOT Analysis

            14.3.2.5. Strategic Overview

        14.3.3. Hologic, Inc.

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Financial Overview

            14.3.3.3. Product Portfolio

            14.3.3.4. SWOT Analysis

            14.3.3.5. Strategic Overview

        14.3.4. Siemens Healthineers (Siemens AG)

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Financial Overview

            14.3.4.3. Product Portfolio

            14.3.4.4. SWOT Analysis

            14.3.4.5. Strategic Overview

        14.3.5. Fujifilm Holding Corporation

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Financial Overview

            14.3.5.3. Product Portfolio

            14.3.5.4. SWOT Analysis

            14.3.5.5. Strategic Overview

        14.3.6. Canon Medical Systems Corporation (Canon Inc.)

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Financial Overview

            14.3.6.3. Product Portfolio

            14.3.6.4. SWOT Analysis

            14.3.6.5. Strategic Overview

        14.3.7. Aurora Imaging Technologies, Inc.

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.7.2. Financial Overview

            14.3.7.3. Product Portfolio

            14.3.7.4. SWOT Analysis

            14.3.7.5. Strategic Overview

        14.3.8. Dilon Technologies, Inc.

            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.8.2. Financial Overview

            14.3.8.3. Product Portfolio

            14.3.8.4. SWOT Analysis

            14.3.8.5. Strategic Overview

        14.3.9. Leica Biosystems Nussloch GmbH (Danaher)

            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.9.2. Financial Overview

            14.3.9.3. Product Portfolio

            14.3.9.4. SWOT Analysis

            14.3.9.5. Strategic Overview

List of Tables

Table 01: Global Risk of Breast Cancer

Table 02: Global Breast Imaging Market Value (US$ Mn) Forecast, by Technology, 2018-2028

Table 03: Global Breast Imaging Market Value (US$ Mn) Forecast, by Ionizing Breast Imaging, 2018-2028

Table 04: Global Breast Imaging Market Value (US$ Mn) Forecast, by Mammography, 2018-2028

Table 05: Global Breast Imaging Market Value (US$ Mn) Forecast, by Non-ionizing Breast Imaging, 2018-2028

Table 06: Global Breast Imaging Market Value (US$ Mn) Forecast, by End-user, 2018-2028

Table 07: Global Breast Imaging Market Value (US$ Mn) Forecast, by Region, 2018-2028

Table 08: North America Breast Imaging Market Value (US$ Mn) Forecast, by Country, 2018-2028

Table 09: North America Breast Imaging Market Value (US$ Mn) Forecast, by Technology, 2018-2028

Table 10: North America Breast Imaging Market Value (US$ Mn) Forecast, by Ionizing Breast Imaging, 2018-2028

Table 11: North America Breast Imaging Market Value (US$ Mn) Forecast, by Mammography, 2018-2028

Table 12: North America Breast Imaging Market Value (US$ Mn) Forecast, by Non-ionizing Breast Imaging, 2018-2028

Table 13: North America Breast Imaging Market Value (US$ Mn) Forecast, by End-user, 2018-2028

Table 14: Europe Breast Imaging Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2028

Table 15: Europe Breast Imaging Market Value (US$ Mn) Forecast, by Technology, 2018-2028

Table 16: Europe Breast Imaging Market Value (US$ Mn) Forecast, by Ionizing Breast Imaging, 2018-2028

Table 17: Europe Breast Imaging Market Value (US$ Mn) Forecast, by Mammography, 2018-2028

Table 18: Europe Breast Imaging Market Value (US$ Mn) Forecast, by Non-ionizing Breast Imaging, 2018-2028

Table 19: Europe Breast Imaging Market Value (US$ Mn) Forecast, by End-user, 2018-2028

Table 20: Asia Pacific Breast Imaging Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2028

Table 21: Asia Pacific Breast Imaging Market Value (US$ Mn) Forecast, by Technology, 2018-2028

Table 22: Asia Pacific Breast Imaging Market Value (US$ Mn) Forecast, by Ionizing Breast Imaging, 2018-2028

Table 23: Asia Pacific Breast Imaging Market Value (US$ Mn) Forecast, by Mammography, 2018-2028

Table 24: Asia Pacific Breast Imaging Market Value (US$ Mn) Forecast, by Non-ionizing Breast Imaging, 2018-2028

Table 25: Asia Pacific Breast Imaging Market Value (US$ Mn) Forecast, by End-user, 2018-2028

Table 26: Latin America Breast Imaging Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2028

Table 27: Latin America Breast Imaging Market Value (US$ Mn) Forecast, by Technology, 2018-2028

Table 28: Latin America Breast Imaging Market Value (US$ Mn) Forecast, by Ionizing Breast Imaging, 2018-2028

Table 29: Latin America Breast Imaging Market Value (US$ Mn) Forecast, by Mammography, 2018-2028

Table 30: Latin America Breast Imaging Market Value (US$ Mn) Forecast, by Non-ionizing Breast Imaging, 2018-2028

Table 31: Latin America Breast Imaging Market Value (US$ Mn) Forecast, by End-user, 2018-2028

Table 32: Middle East & Africa Breast Imaging Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2028

Table 33: Middle East & Africa Breast Imaging Market Value (US$ Mn) Forecast, by Technology, 2018-2028

Table 34: Middle East & Africa Breast Imaging Market Value (US$ Mn) Forecast, by Ionizing Breast Imaging, 2018-2028

Table 35: Middle East & Africa Breast Imaging Market Value (US$ Mn) Forecast, by Mammography, 2018-2028

Table 36: Middle East & Africa Breast Imaging Market Value (US$ Mn) Forecast, by Non-ionizing Breast Imaging, 2018-2028

Table 37: Middle East & Africa Breast Imaging Market Value (US$ Mn) Forecast, by End-user, 2018-2028

List of Figures

Figure 01: Global Breast Imaging Market Value (US$ Mn) and Distribution (%), by Region, 2019 and 2028

Figure 02: Global Breast Imaging Market Size (US$ Mn) and Forecast, 2020-2028

Figure 03: Global Breast Imaging Market Value Share (%), by Technology, 2019

Figure 04: Global Breast Imaging Market Value Share (%), by Region, 2019

Figure 05: Global Breast Imaging Market Value Share (%), by End-user, 2019

Figure 06: Global Breast Imaging Market Value Share Analysis, by Technology, 2019 and 2028

Figure 07: Global Breast Imaging Market Attractiveness, by Technology, 2020-2028

Figure 08: Global Breast Imaging Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ionizing Breast Imaging, 2018-2028

Figure 09: Global Breast Imaging Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Non-ionizing Breast Imaging, 2018-2028

Figure 10: Global Breast Imaging Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2018-2028

Figure 11: Global Breast Imaging Market Value Share, by End-user, 2019 and 2028

Figure 12: Global Breast Imaging Market Attractiveness, by End-user, 2020-2028

Figure 13: Global Breast Imaging Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals & Clinics, 2018-2028

Figure 14: Global Breast Imaging Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Centers, 2018-2028

Figure 15: Global Breast Imaging Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ambulatory Surgical Centers, 2018-2028

Figure 16: Global Breast Imaging Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Research Centers, 2018-2028

Figure 17: Global Breast Imaging Market Value Share, by Region, 2019 and 2028

Figure 18: Global Breast Imaging Market Attractiveness, by Region, 2020-2028

Figure 19: North America Breast Imaging Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2028

Figure 20: North America Breast Imaging Market Value Share Analysis, by Country, 2019 and 2028

Figure 21: North America Breast Imaging Market Attractiveness, by Country, 2020-2028

Figure 22: North America Breast Imaging Market Value Share Analysis, by Technology, 2019 and 2028

Figure 23: North America Breast Imaging Market Attractiveness, by Technology, 2020-2028

Figure 24: North America Breast Imaging Market Value Share, by End-user, 2019 and 2028

Figure 25: North America Breast Imaging Market Attractiveness, by End-user, 2020-2028

Figure 26: Europe Breast Imaging Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2028

Figure 27: Europe Breast Imaging Market Value Share Analysis, by Countries/Sub-region, 2019 and 2028

Figure 28: Europe Breast Imaging Market Attractiveness, by Countries/Sub-region, 2020-2028

Figure 29: Europe Breast Imaging Market Value Share Analysis, by Technology, 2019 and 2028

Figure 30: Europe Breast Imaging Market Attractiveness, by Technology, 2020-2028

Figure 31: Europe Breast Imaging Market Value Share, by End-user, 2019 and 2028

Figure 32: Europe Breast Imaging Market Attractiveness, by End-user, 2020-2028

Figure 33: Asia Pacific Breast Imaging Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2028

Figure 34: Asia Pacific Breast Imaging Market Value Share Analysis, by Countries/Sub-region, 2019 and 2028

Figure 35: Asia Pacific Breast Imaging Market Attractiveness, by Countries/Sub-region, 2020-2028

Figure 36: Asia Pacific Breast Imaging Market Value Share Analysis, by Technology, 2019 and 2028

Figure 37: Asia Pacific Breast Imaging Market Attractiveness, by Technology, 2020-2028

Figure 38: Asia Pacific Breast Imaging Market Value Share, by End-user, 2019 and 2028

Figure 39: Asia Pacific Breast Imaging Market Attractiveness, by End-user, 2020-2028

Figure 40: Latin America Breast Imaging Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2028

Figure 41: Latin America Breast Imaging Market Value Share Analysis, by Countries/Sub-region, 2019 and 2028

Figure 42: Latin America Breast Imaging Market Attractiveness, by Countries/Sub-region, 2020-2028

Figure 43: Latin America Breast Imaging Market Value Share Analysis, by Technology, 2019 and 2028

Figure 44: Latin America Breast Imaging Market Attractiveness, by Technology, 2020-2028

Figure 45: Latin America Breast Imaging Market Value Share, by End-user, 2019 and 2028

Figure 46: Latin America Breast Imaging Market Attractiveness, by End-user, 2020-2028

Figure 47: Middle East & Africa Breast Imaging Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2028

Figure 48: Middle East & Africa Breast Imaging Market Value Share Analysis, by Countries/Sub-region, 2019 and 2028

Figure 49: Middle East & Africa Breast Imaging Market Attractiveness, by Countries/Sub-region, 2020-2028

Figure 50: Middle East & Africa Breast Imaging Market Value Share Analysis, by Technology, 2019 and 2028

Figure 51: Middle East & Africa Breast Imaging Market Attractiveness, by Technology, 2020-2028

Figure 52: Middle East & Africa Breast Imaging Market Value Share, by End-user, 2019 and 2028

Figure 53: Middle East & Africa Breast Imaging Market Attractiveness, by End-user, 2020-2028

Figure 54: Global Breast Imaging Market Share, by Company, 2018

Figure 55: GE Healthcare Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 56: GE Healthcare Breakdown of Net Sales (%), by Region, 2018

Figure 57: GE Healthcare Breakdown of Net Sales (%), by Business Segment, 2018

Figure 58: Koninklijke Philips N.V. Revenue (US$ Mn) and Y-o-Y Growth (%),

Figure 59: Koninklijke Philips N.V., Breakdown of Net Sales (%), by Region, 2018

Figure 60: Koninklijke Philips N.V., Breakdown of Net Sales (%), by Business Segment, 2018

Figure 61: Hologic, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2019

Figure 62: Hologic Inc., Breakdown of Net Sales (%), by Region, 2019

Figure 63: Hologic, Inc., Breakdown of Net Sales (%), by Business Segment, 2019

Figure 64: Siemens Healthineers Revenue (US$ Bn) and Y-o-Y Growth (%), 2014-2018

Figure 65: Siemens Healthineers Diagnostics Business Segment, Breakdown of Net Sales (%), by Region, 2018

Figure 66: Siemens Healthineers Diagnostics Business Segment, Breakdown of Net Sales (%), by Business Segment, 2018

Figure 67: Fujifilm Holding Corporation Revenue (US$ Bn) and Y-o-Y Growth (%), 2014-2018

Figure 68: Fujifilm Holding Corporation Breakdown of Net Sales (%), by Segment, 2018-2019

Figure 69: CANON MEDICAL SYSTEMS CORPORATION (Canon Inc.) Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 70: CANON MEDICAL SYSTEMS CORPORATION (Canon Inc.) – Medical Systems Business Segment Breakdown of Net Sales (%), by Region, 2018

Figure 71: CANON MEDICAL SYSTEMS CORPORATION (Canon Inc.) Breakdown of Net Sales (%), by Business Segment, 2018

Figure 72: Danaher (Diagnostics) Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2019

Figure 73: Danaher (Diagnostics) Breakdown of Net Sales, by Region, 2019

Copyright © Transparency Market Research, Inc. All Rights reserved

Breast Imaging Market

Schedule a Call